Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLA | P06280 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.49 |
| ▸ | MAPT | P10636 | 4/20 | 0.49 |
| ▸ | ATM | Q13315 | 3/20 | 0.49 |
| ▸ | HPGD | P15428 | 3/20 | 0.49 |
| ▸ | HTT | P42858 | 3/20 | 0.49 |
| ▸ | LMNA | P02545 | 3/20 | 0.49 |
| ▸ | CACNA1B | Q00975 | 2/20 | 0.49 |
| ▸ | APBA1 | Q02410 | 2/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.49 |
| ▸ | TP53 | P04637 | 2/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.43 |
| ▸ | MEN1 | O00255 | 4/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 2/20 | 0.42 |
| ▸ | PKM | P14618 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13477928 | 0.85 | KMT2A (0.50) | GLAALDH1A1HSD17B10MAPTHPGD | |
| SCHEMBL13133148 | 0.84 | HSD17B10 (0.54) | GLAALDH1A1HSD17B10MAPTHTT | |
| SCHEMBL4391609 | 0.82 | MGLL (0.49) | ALDH1A1ATMHPGDHTTLMNA | |
| SCHEMBL13477927 | 0.81 | KMT2A (0.47) | GLAALDH1A1HSD17B10MAPTHPGD | |
| SCHEMBL13477971 | 0.81 | KMT2A (0.47) | ALDH1A1MAPTHPGDHTTLMNA | |
| SCHEMBL94147 | 0.81 | MGLL (0.46) | NPSR1MAPK1RAB9AKMT2AMEN1 | |
| SCHEMBL28434246 | 0.80 | MGLL (0.59) | ALDH1A1HSD17B10MAPTHTTLMNA | |
| SCHEMBL9064941 | 0.79 | KMT2A (0.46) | ALDH1A1MAPTHPGDHTTLMNA | |
| SCHEMBL13900316 | 0.79 | GLA (0.51) | GLAALDH1A1HSD17B10MAPTATM | |
| SCHEMBL5073167 | 0.78 | GLA (0.67) | GLAALDH1A1HSD17B10MAPTATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130299747-A1 | CURATIVES FOR EPOXY COMPOSITIONSERS | DESIGNER MOLECULES, INC. | 2013-11-14 | — | — | US | disclosed |
| US-20130299747-A1 | CURATIVES FOR EPOXY COMPOSITIONSERS | DESIGNER MOLECULES, INC. | 2013-11-14 | — | — | US | disclosed |
| US-20130199724-A1 | CURATIVES FOR EPOXY COMPOSITIONS | DESIGNER MOLECULES, INC. (US) | 2013-08-08 | — | — | US | disclosed |
| US-20130199724-A1 | CURATIVES FOR EPOXY COMPOSITIONS | DESIGNER MOLECULES, INC. (US) | 2013-08-08 | — | — | US | disclosed |
| US-8431655-B2 | Curatives for epoxy compositions | DESIGNER MOLECULES, INC. (US) | 2013-04-30 | — | — | US | disclosed |
| US-8431655-B2 | Curatives for epoxy compositions | DESIGNER MOLECULES, INC. (US) | 2013-04-30 | — | — | US | disclosed |
| US-20100249276-A1 | CURATIVES FOR EPOXY COMPOSITIONS | DESIGNER MOLECULES, INC. (US) | 2010-09-30 | — | — | US | disclosed |
| US-20100249276-A1 | CURATIVES FOR EPOXY COMPOSITIONS | DESIGNER MOLECULES, INC. (US) | 2010-09-30 | — | — | US | disclosed |
| US-20100113643-A1 | CURATIVES FOR EPOXY ADHESIVE COMPOSITIONS | DESIGNER MOLECULES, INC. (US) | 2010-05-06 | — | — | US | disclosed |
| US-20100113643-A1 | CURATIVES FOR EPOXY ADHESIVE COMPOSITIONS | DESIGNER MOLECULES, INC. (US) | 2010-05-06 | — | — | US | disclosed |
| US-5221717-A | CITRACONIMIDE (CO)POLYMERS AND CURING WITH ANIONIC CATALYST | AKZO N.V. (NL) | 1993-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100249276-A1 | CURATIVES FOR EPOXY COMPOSITIONS | ALOX5, LTC4S, ALOX15B | GLA 2797/4885ALDH1A1 211/4885HSD17B10 551/4885 |
| US-20100113643-A1 | CURATIVES FOR EPOXY ADHESIVE COMPOSITIONS | ALOX5, LTC4S, ALOX15B | GLA 2951/4885ALDH1A1 144/4885HSD17B10 548/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.